Sisram Medical (HKG:1696) reported a profit attributable to the owners of $25.1 million for 2024, down from $31.5 million a year earlier.
Earnings per share were $0.0536, a decline from $0.0673 in the same period last year, according to a Wednesday filing with the Hong Kong bourse.
Revenue dropped 2.8% to $349.1 million from $359.3 million the previous year.
The board resolved to declare a final dividend of HK$0.126 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.